Author:
Jaswal Jasbir,Crook Juanita
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Huggins C, Hodges CV. Studies on prostatic cancer: I. the effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. J Urol. 2002;168(1):9–12.
2. Klotz LH, Herr HW, Morse MJ, Whitmore Jr WF. Intermittent endocrine therapy for advanced prostate cancer. Cancer. 1986;58(11):2546–50.
3. Bruchovsky N, Rennie PS, Coldman AJ, Goldenberg SL, To M, Lawson D. Effects of androgen withdrawal on the stem cell composition of the shionogi carcinoma. Cancer Res. 1990;50(8):2275–82.
4. Akakura K, Bruchovsky N, Goldenberg SL, Rennie PS, Buckley AR, Sullivan LD. Effects of intermittent androgen suppression on androgen-dependent tumors. apoptosis and serum prostate-specific antigen. Cancer. 1993;71(9):2782–90.
5. Higano CS, Ellis W, Russell K, Lange PH. Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: a pilot study. Urology. 1996;48(5):800–4.